Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation

Buprenorphine-naloxone (BUP-NX) is a lifesaving treatment for opioid use disorder. The increasing use of illicitly manufactured fentanyl, however, has made initiating BUP-NX more likely to precipitate withdrawal—an experience that deters treatment and causes return to use. If BUP-NX cannot be succes...

Descripción completa

Detalles Bibliográficos
Autores principales: Randall, Adam, Hull, Ilana, Martin, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022654/
https://www.ncbi.nlm.nih.gov/pubmed/36149001
http://dx.doi.org/10.1097/ADM.0000000000001073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022654/
https://www.ncbi.nlm.nih.gov/pubmed/36149001
http://dx.doi.org/10.1097/ADM.0000000000001073

Ejemplares similares